Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges

Clinical Pharmacology & TherapeuticsEarly View Perspective Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges Zhu Zhou, Corresponding Author Zhu Zhou zzhou1@york.cuny.edu Department of Chemistry, York College, City University of New York, Jamaica, New York, USA Correspondence: Zhu Zhou (zzhou1@york.cuny.edu); Lei Zhang (leik.zhang@fda.hhs.gov)Search for more papers by this authorMary F. Paine, Mary F. Paine Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USASearch for more papers by this authorTory R. Spindle, Tory R. Spindle Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USASearch for more papers by this authorShiew-Mei Huang, Shiew-Mei Huang Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USASearch for more papers by this authorLei Zhang, Corresponding Author Lei Zhang leik.zhang@fda.hhs.gov Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA Correspondence: Zhu Zhou (zzhou1@york.cuny.edu); Lei Zhang (leik.zhang@fda.hhs.gov)Search for more papers by this author Zhu Zhou, Corresponding Author Zhu Zhou zzhou1@york.cuny.edu Department of Chemistry, York College, City University of New York, Jamaica, New York, USA Correspondence: Zhu Zhou (zzhou1@york.cuny.edu); Lei Zhang (leik.zhang@fda.hhs.gov)Search for more papers by this authorMary F. Paine, Mary F. Paine Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USASearch for more papers by this authorTory R. Spindle, Tory R. Spindle Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USASearch for more papers by this authorShiew-Mei Huang, Shiew-Mei Huang Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USASearch for more papers by this authorLei Zhang, Corresponding Author Lei Zhang leik.zhang@fda.hhs.gov Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA Correspondence: Zhu Zhou (zzhou1@york.cuny.edu); Lei Zhang (leik.zhang@fda.hhs.gov)Search for more papers by this author First published: 16 November 2021 https://doi.org/10.1002/cpt.2470Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Early ViewOnline Version of Record before inclusion in an issue RelatedInformation